| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | VX-11e | GDSC1000 | pan-cancer | AAC | -0.16 | 5e-06 |
| mRNA | PD-0325901 | CCLE | pan-cancer | AAC | -0.18 | 2e-05 |
| mRNA | AC220 | GDSC1000 | pan-cancer | AAC | -0.15 | 4e-05 |
| mRNA | Lisitinib | GDSC1000 | pan-cancer | AAC | -0.13 | 0.0001 |
| mRNA | AEW541 | CCLE | pan-cancer | AAC | -0.18 | 0.0001 |
| mRNA | MPS-1-IN-1 | GDSC1000 | pan-cancer | AAC | -0.12 | 0.0002 |
| mRNA | selumetinib:piperlongumine (8:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.13 | 0.0003 |
| mRNA | VNLG/124 | GDSC1000 | pan-cancer | AAC | -0.12 | 0.0004 |
| mRNA | AZD6244 | CCLE | pan-cancer | AAC | -0.16 | 0.0004 |
| mRNA | linifanib | GDSC1000 | pan-cancer | AAC | -0.13 | 0.0005 |